Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNTX Context Therapeutics Inc.

盘前交易 12-16 07:38:35 EST

1.13

+0.09

+8.65%

最高1.16	最低1.04	成交量153.77万
今开1.05	昨收1.04	日振幅11.54%
总市值1.04亿	流通市值4,505万	总股本9,188万
成交额165.04万	换手率3.86%	流通股本3,987万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNTX","market":"US","secType":"STK","nameCN":"Context Therapeutics Inc.","latestPrice":1.13,"timestamp":1765832400000,"preClose":1.04,"halted":0,"volume":1537742,"delay":0,"floatShares":39871400,"shares":91879177,"eps":-0.2878,"marketStatus":"盘前交易","change":0.09,"latestTime":"12-16 07:38:35 EST","open":1.05,"high":1.16,"low":1.04,"amount":1650395.7487264,"amplitude":0.115385,"askPrice":1.16,"askSize":29,"bidPrice":1.02,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.2878,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765895400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1634702400000,"exchange":"NASDAQ","adjPreClose":1.13,"postHourTrading":{"tag":"盘后","latestPrice":1.1332,"preClose":1.13,"latestTime":"19:58 EST","volume":1062,"amount":1186.3225,"timestamp":1765846717379},"volumeRatio":2.475647487254646},"requestUrl":"/m/hq/s/CNTX","defaultTab":"news","newsList":[{"id":"1164253746","title":"Context Therapeutics 修改销售协议，可能会不时提供和出售最多7500万美元的普通股 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1164253746","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164253746?lang=zh_cn&edition=full","pubTime":"2025-10-25 04:05","pubTimestamp":1761336312,"startTime":"0","endTime":"0","summary":"Context Therapeutics 修改销售协议，可能会不时提供和出售最多7500万美元的普通股 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","BK4007"],"gpt_icon":0},{"id":"2537132535","title":"Context Therapeutics Inc.盘中异动 股价大跌6.14%报0.662美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537132535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537132535?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:43","pubTimestamp":1748007798,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时43分，Context Therapeutics Inc.股票出现异动，股价快速下挫6.14%。截至发稿，该股报0.662美元/股，成交量2.123万股，换手率0.02%，振幅0.01%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc是一家处于临床阶段的生物制药公司，致力于推进针对实体肿瘤的药物开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523214319a489c82e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523214319a489c82e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4007","CNTX","BK4139"],"gpt_icon":0},{"id":"2536860348","title":"Context Therapeutics Inc.2025财年第一财季实现净利润-4.58百万美元，同比减少24.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536860348","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536860348?lang=zh_cn&edition=full","pubTime":"2025-05-17 00:00","pubTimestamp":1747411236,"startTime":"0","endTime":"0","summary":"5月17日，Context Therapeutics Inc.公布财报，公告显示公司2025财年第一财季净利润为-4.58百万美元，同比减少24.80%；其中营业收入为0.00美元，每股基本收益为-0.05美元。机构评级：截至2025年5月17日，当前有5家机构对Context Therapeutics Inc.目标价做出预测，其中目标均价为5.50美元，其中最低目标价为4.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517000305a4811905&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517000305a4811905&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX"],"gpt_icon":0},{"id":"2535315478","title":"Context Therapeutics Inc.盘中异动 股价大跌6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535315478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535315478?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:32","pubTimestamp":1747402337,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时32分，Context Therapeutics Inc.股票出现异动，股价大幅跳水6.53%。截至发稿，该股报0.701美元/股，成交量2288股，换手率0.00%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc是一家处于临床阶段的生物制药公司，致力于推进针对实体肿瘤的药物开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213218aa2c9111&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213218aa2c9111&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","CNTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2535873825","title":"Context Therapeutics Inc.盘中异动 临近午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535873825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535873825?lang=zh_cn&edition=full","pubTime":"2025-05-15 23:51","pubTimestamp":1747324289,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日23时51分，Context Therapeutics Inc.股票出现异动，股价快速跳水5.08%。截至发稿，该股报0.750美元/股，成交量1.1951万股，换手率0.01%，振幅4.22%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.39%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc是一家处于临床阶段的生物制药公司，致力于推进针对实体肿瘤的药物开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515235130aa2c9038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515235130aa2c9038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","CNTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2535800168","title":"Context Therapeutics Inc.盘中异动 下午盘大幅下跌6.09%报0.770美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535800168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535800168?lang=zh_cn&edition=full","pubTime":"2025-05-15 02:58","pubTimestamp":1747249129,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日02时58分，Context Therapeutics Inc.股票出现波动，股价急速下挫6.09%。截至发稿，该股报0.770美元/股，成交量5.6776万股，换手率0.06%，振幅7.01%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc是一家处于临床阶段的生物制药公司，致力于推进针对实体肿瘤的药物开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515025849a6df4f25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515025849a6df4f25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CNTX","BK4007","BK4539"],"gpt_icon":0},{"id":"2517165513","title":"Context Therapeutics Inc.盘中异动 早盘急速上涨6.89%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517165513?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271534,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Context Therapeutics Inc.股票出现波动，股价快速上涨6.89%。截至发稿，该股报0.900美元/股，成交量9448股，换手率0.01%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为954.97%、104.38%、49.12%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223215abeb77cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223215abeb77cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2514486746","title":"Context Therapeutics Inc.盘中异动 快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514486746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514486746?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:00","pubTimestamp":1740603608,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日05时00分，Context Therapeutics Inc.股票出现波动，股价急速拉升5.10%。截至发稿，该股报0.856美元/股，成交量6.3169万股，换手率0.08%，振幅4.95%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227050008abde40d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227050008abde40d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CNTX"],"gpt_icon":0},{"id":"2513129634","title":"Context Therapeutics Inc.盘中异动 早盘快速拉升7.47%报0.849美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513129634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513129634?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148273,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Context Therapeutics Inc.股票出现异动，股价快速上涨7.47%。截至发稿，该股报0.849美元/股，成交量5962股，换手率0.01%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Osr Holdings, Inc.、Nkgen Biotech, Inc.、Acelyrin, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为69.02%、60.21%、17.19%，振幅较大的相关个股有Osr Holdings, Inc.、Gain Therapeutics, Inc.、Windtree Therapeutics, Inc.，振幅分别为11.30%、10.21%、7.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223113abd7af45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223113abd7af45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CNTX"],"gpt_icon":0},{"id":"2512649561","title":"Context Therapeutics Inc.盘中异动 快速拉升6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512649561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512649561?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:52","pubTimestamp":1739893965,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时52分，Context Therapeutics Inc.股票出现波动，股价大幅上涨6.13%。截至发稿，该股报0.872美元/股，成交量1.2219万股，换手率0.02%，振幅2.56%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218235245abd3c187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218235245abd3c187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2509206743","title":"Context Therapeutics Inc.盘中异动 临近午盘快速下挫5.20%报0.907美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509206743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509206743?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:32","pubTimestamp":1738859553,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时32分，Context Therapeutics Inc.股票出现异动，股价急速下挫5.20%。截至发稿，该股报0.907美元/股，成交量3.5707万股，换手率0.05%，振幅7.54%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003233a23be88c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003233a23be88c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2509280445","title":"Context Therapeutics Inc.盘中异动 早盘股价大涨9.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509280445?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:17","pubTimestamp":1738768654,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时17分，Context Therapeutics Inc.股票出现波动，股价急速上涨9.02%。截至发稿，该股报0.958美元/股，成交量1946股，换手率0.00%，振幅4.99%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3901.91%、1140.99%、671.38%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231734abc387d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231734abc387d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CNTX"],"gpt_icon":0},{"id":"2508290450","title":"Context Therapeutics Inc.盘中异动 快速拉升5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508290450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508290450?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:53","pubTimestamp":1738680817,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时53分，Context Therapeutics Inc.股票出现波动，股价急速拉升5.52%。截至发稿，该股报0.920美元/股，成交量1793股，换手率0.00%，振幅1.14%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1307.05%、823.17%、199.89%，振幅较大的相关个股有Azitra Inc、Briacell Therapeutics Corp C/Wts 24/02/2025、Invivyd, Inc.，振幅分别为49.48%、40.00%、29.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225337987a4e58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225337987a4e58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2507679910","title":"Context Therapeutics Inc.盘中异动 股价大涨6.05%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507679910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507679910?lang=zh_cn&edition=full","pubTime":"2025-01-31 01:57","pubTimestamp":1738259870,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日01时57分，Context Therapeutics Inc.股票出现异动，股价快速上涨6.05%。截至发稿，该股报0.870美元/股，成交量8.5836万股，换手率0.11%，振幅4.83%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Nutriband Inc C/Wts 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1749.47%、272.95%、233.36%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、63.82%、61.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131015750a2347791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131015750a2347791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2506301496","title":"Context Therapeutics Inc.盘中异动 早盘股价大涨5.20%报0.949美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506301496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506301496?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:04","pubTimestamp":1737993896,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时04分，Context Therapeutics Inc.股票出现异动，股价快速上涨5.20%。截至发稿，该股报0.949美元/股，成交量5172股，换手率0.01%，振幅4.52%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为1968.51%、454.97%、218.26%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为86.84%、85.35%、65.16%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128000456abba74b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128000456abba74b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CNTX"],"gpt_icon":0},{"id":"2505012557","title":"Context Therapeutics Inc.盘中异动 快速拉升6.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505012557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505012557?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:01","pubTimestamp":1737644476,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时01分，Context Therapeutics Inc.股票出现波动，股价快速拉升6.60%。截至发稿，该股报1.000美元/股，成交量1.8867万股，换手率0.03%，振幅0.01%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230117abb600e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230117abb600e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CNTX"],"gpt_icon":0},{"id":"2503422990","title":"Context Therapeutics Inc.盘中异动 股价大涨5.08%报1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503422990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503422990?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:30","pubTimestamp":1737037859,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时30分，Context Therapeutics Inc.股票出现异动，股价大幅上涨5.08%。截至发稿，该股报1.030美元/股，成交量4745股，换手率0.01%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622305998688b65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622305998688b65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2503647063","title":"Context Therapeutics Inc.盘中异动 大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503647063?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:30","pubTimestamp":1736951447,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时30分，Context Therapeutics Inc.股票出现异动，股价快速拉升5.03%。截至发稿，该股报1.040美元/股，成交量7.4565万股，换手率0.10%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Eterna Therapeutics Inc.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为183.10%、52.56%、49.47%，振幅较大的相关个股有Vincerx Pharma, Inc.、Onconetix, Inc.、Cibus, Inc.，振幅分别为10.37%、9.31%、7.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223047a222fd4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223047a222fd4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2501778736","title":"Context Therapeutics Inc.盘中异动 早盘大幅上涨8.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501778736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501778736?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:31","pubTimestamp":1736346682,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时31分，Context Therapeutics Inc.股票出现波动，股价急速拉升8.26%。截至发稿，该股报1.18美元/股，成交量2.6059万股，换手率0.03%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223122a21a526b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223122a21a526b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CNTX"],"gpt_icon":0},{"id":"2500119261","title":"Context Therapeutics Inc.盘中异动 早盘快速拉升8.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500119261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500119261?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:31","pubTimestamp":1735914708,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时31分，Context Therapeutics Inc.股票出现波动，股价急速上涨8.40%。截至发稿，该股报1.29美元/股，成交量5953股，换手率0.01%，振幅0.84%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223148ab9d5a57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223148ab9d5a57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CNTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.contexttherapeutics.com","stockEarnings":[{"period":"1week","weight":0.066},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.3329},{"period":"6month","weight":1.0046},{"period":"1year","weight":-0.1871},{"period":"ytd","weight":0.0762}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Context Therapeutics Inc.于2015年4月在特拉华州成立。这是一家临床阶段的生物制药公司，致力于改善罹患癌症的妇女的生活。肿瘤学药物开发的深远进展扩大了癌症女性可获得的治疗选择，但是治疗耐药性和复发继续限制了此类治疗的功效和持续时间。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.041474},{"month":2,"riseRate":0.25,"avgChangeRate":-0.065627},{"month":3,"riseRate":0.5,"avgChangeRate":-0.053897},{"month":4,"riseRate":0.5,"avgChangeRate":0.023173},{"month":5,"riseRate":0.75,"avgChangeRate":0.295099},{"month":6,"riseRate":0.75,"avgChangeRate":0.233367},{"month":7,"riseRate":0.5,"avgChangeRate":-0.057392},{"month":8,"riseRate":0.75,"avgChangeRate":0.057821},{"month":9,"riseRate":0.5,"avgChangeRate":0.000078},{"month":10,"riseRate":0.75,"avgChangeRate":0.018618},{"month":11,"riseRate":0.6,"avgChangeRate":-0.036732},{"month":12,"riseRate":0.4,"avgChangeRate":-0.222399}],"exchange":"NASDAQ","name":"Context Therapeutics Inc.","nameEN":"Context Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Context Therapeutics Inc.,CNTX,Context Therapeutics Inc.股票,Context Therapeutics Inc.股票老虎,Context Therapeutics Inc.股票老虎国际,Context Therapeutics Inc.行情,Context Therapeutics Inc.股票行情,Context Therapeutics Inc.股价,Context Therapeutics Inc.股市,Context Therapeutics Inc.股票价格,Context Therapeutics Inc.股票交易,Context Therapeutics Inc.股票购买,Context Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}